Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2719208 | The American Journal of Medicine | 2009 | 11 Pages |
Abstract
Long-term home treatment with tinzaparin or usual care resulted in similar rates of recurrent venous thromboembolism, death, and bleeding. The significantly lower incidence of post-thrombotic syndrome and leg ulcers observed in the tinzaparin group is a potentially important benefit and deserves further study.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Russell D. MBBS, MSc, Graham F. MD, Rollin PhD, Jane MSc, Roy MD, Susan MD, Man-Chiu MD, MSc, Gary PhD, LITE Trial Investigators LITE Trial Investigators,